Park Avenue Securities LLC raised its stake in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 20.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 10,276 shares of the semiconductor company's stock after acquiring an additional 1,732 shares during the period. Park Avenue Securities LLC's holdings in Synopsys were worth $4,988,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Dimensional Fund Advisors LP lifted its stake in shares of Synopsys by 16.8% in the 2nd quarter. Dimensional Fund Advisors LP now owns 303,784 shares of the semiconductor company's stock worth $180,779,000 after acquiring an additional 43,785 shares during the period. Mesirow Financial Investment Management Inc. purchased a new position in Synopsys during the second quarter worth about $203,000. Bradley Foster & Sargent Inc. CT lifted its position in Synopsys by 13.4% in the second quarter. Bradley Foster & Sargent Inc. CT now owns 12,090 shares of the semiconductor company's stock valued at $7,194,000 after purchasing an additional 1,430 shares during the period. Argent Trust Co boosted its holdings in Synopsys by 12.1% in the 2nd quarter. Argent Trust Co now owns 464 shares of the semiconductor company's stock valued at $276,000 after purchasing an additional 50 shares in the last quarter. Finally, Blair William & Co. IL increased its position in Synopsys by 3.5% during the 2nd quarter. Blair William & Co. IL now owns 43,443 shares of the semiconductor company's stock worth $25,851,000 after purchasing an additional 1,451 shares during the period. 85.47% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several analysts have recently commented on the company. Wells Fargo & Company reduced their price target on Synopsys from $570.00 to $540.00 and set an "equal weight" rating for the company in a report on Monday. Redburn Atlantic assumed coverage on Synopsys in a research report on Monday. They issued a "buy" rating and a $600.00 price objective for the company. Robert W. Baird decreased their target price on shares of Synopsys from $644.00 to $630.00 and set an "outperform" rating on the stock in a research report on Thursday, December 5th. Rosenblatt Securities reaffirmed a "buy" rating and set a $635.00 price target on shares of Synopsys in a research note on Wednesday, December 4th. Finally, Berenberg Bank initiated coverage on shares of Synopsys in a research note on Tuesday, October 15th. They issued a "buy" rating and a $660.00 price objective for the company. One analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company. Based on data from MarketBeat.com, Synopsys has an average rating of "Moderate Buy" and an average target price of $641.82.
Read Our Latest Analysis on SNPS
Insider Activity at Synopsys
In other news, CRO Richard S. Mahoney sold 20,838 shares of the business's stock in a transaction on Wednesday, January 15th. The stock was sold at an average price of $506.01, for a total value of $10,544,236.38. Following the completion of the transaction, the executive now directly owns 1,460 shares of the company's stock, valued at $738,774.60. The trade was a 93.45 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 0.66% of the stock is owned by corporate insiders.
Synopsys Trading Up 2.1 %
Shares of SNPS stock traded up $10.89 during trading hours on Friday, hitting $526.70. The company's stock had a trading volume of 1,240,502 shares, compared to its average volume of 1,044,771. The business has a fifty day moving average of $519.43 and a 200-day moving average of $526.69. Synopsys, Inc. has a twelve month low of $457.52 and a twelve month high of $629.38. The stock has a market cap of $81.42 billion, a price-to-earnings ratio of 36.27, a P/E/G ratio of 3.22 and a beta of 1.12.
Synopsys Company Profile
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Further Reading
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.